HudsonAlpha Institute has launched a pilot study focusing on the role of genetics and lifestyle in the development of Alzheimer’s disease and related dementias. The study, called HOPE AD, is enrolling 200 healthy adults aged between 65 and 75 with a family history of dementia but no cognitive impairment. Participants will undergo medical exams, cognitive testing, and receive clinical results including genetic information and biomarker levels.
Lead researcher Nick Cochran emphasizes the importance of early prevention, stating that Alzheimer’s disease begins years before symptoms appear. The study aims to empower participants to make lifestyle changes that may protect brain health. Using a “phenomic” approach, the study gathers detailed information about participants’ health, environment, and lifestyle to paint a more comprehensive picture of dementia risk.
Results from the pilot study will inform a larger study in the future. To learn more about the HOPE AD study or determine eligibility, interested individuals can contact the Smith Family Clinic for Genomic Medicine.
This groundbreaking research by HudsonAlpha Institute shows promise in understanding and potentially preventing Alzheimer’s disease and related dementias. With a focus on personalized health information and early intervention, the study aims to shift from reactive to proactive approaches in managing cognitive decline. Stay tuned for further developments in this important field of study.
Source
Note: The image is for illustrative purposes only and is not the original image of the presented article.
